Literature DB >> 24500404

Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation.

Michael T Beste1, Nicole Pfäffle-Doyle, Emily A Prentice, Stephanie N Morris, Douglas A Lauffenburger, Keith B Isaacson, Linda G Griffith.   

Abstract

Clinical management of endometriosis is limited by the complex relationship between symptom severity, heterogeneous surgical presentation, and variability in clinical outcomes. As a complement to visual classification schemes, molecular profiles of disease activity may improve risk stratification to better inform treatment decisions and identify new approaches to targeted treatment. We use a network analysis of information flow within and between inflammatory cells to discern consensus behaviors characterizing patient subpopulations. Unsupervised multivariate analysis of cytokine profiles quantified by multiplex immunoassays identified a subset of patients with a shared "consensus signature" of 13 elevated cytokines that was associated with common clinical features of endometriosis, but was not observed among patient subpopulations defined by morphologic presentation alone. Enrichment analysis of consensus markers reinforced the primacy of peritoneal macrophage infiltration and activation, which was demonstrably elevated in ex vivo cultures. Although familiar targets of the nuclear factor κB family emerged among overrepresented transcriptional binding sites for consensus markers, our analysis provides evidence for an unexpected contribution from c-Jun, c-Fos, and AP-1 effectors of mitogen-associated kinase signaling. Their crucial involvement in propagation of macrophage-driven inflammatory networks was confirmed via targeted inhibition of upstream kinases. Collectively, these analyses suggest a clinically relevant inflammatory network that may serve as an objective measure for guiding treatment decisions for endometriosis management, and in the future may provide a mechanistic endpoint for assessing efficacy of new agents aimed at curtailing inflammatory mechanisms that drive disease progression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24500404      PMCID: PMC4118592          DOI: 10.1126/scitranslmed.3007988

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  50 in total

1.  R2KS: a novel measure for comparing gene expression based on ranked gene lists.

Authors:  Shengyu Ni; Martin Vingron
Journal:  J Comput Biol       Date:  2012-06       Impact factor: 1.479

2.  Revised endometriosis classification: 1996.

Authors:  R S Schenken; D S Guzick
Journal:  Fertil Steril       Date:  1997-05       Impact factor: 7.329

3.  Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis.

Authors:  J Szamatowicz; P Laudański; I Tomaszewska
Journal:  Hum Reprod       Date:  2002-02       Impact factor: 6.918

4.  Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  A Vodolazkaia; Y El-Aalamat; D Popovic; A Mihalyi; X Bossuyt; C M Kyama; A Fassbender; A Bokor; D Schols; D Huskens; C Meuleman; K Peeraer; C Tomassetti; O Gevaert; E Waelkens; A Kasran; B De Moor; T M D'Hooghe
Journal:  Hum Reprod       Date:  2012-06-26       Impact factor: 6.918

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  Profiling of peritoneal fluid of women with endometriosis by chemokine protein array.

Authors:  P Laudański; J Szamatowicz; M Oniszczuk
Journal:  Adv Med Sci       Date:  2006       Impact factor: 3.287

7.  Proteomic analysis of serum yields six candidate proteins that are differentially regulated in a subset of women with endometriosis.

Authors:  Beata Seeber; Mary D Sammel; Xuejun Fan; George L Gerton; Alka Shaunik; Jesse Chittams; Kurt T Barnhart
Journal:  Fertil Steril       Date:  2009-02-20       Impact factor: 7.329

8.  Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis.

Authors:  Jacek Kabut; Zdzisława Kondera-Anasz; Justyna Sikora; Aleksandra Mielczarek-Palacz
Journal:  Fertil Steril       Date:  2007-05-04       Impact factor: 7.329

9.  Autoimmunity to endometrium and ovary in endometriosis.

Authors:  S Mathur; M R Peress; H O Williamson; C D Youmans; S A Maney; A J Garvin; P F Rust; H H Fudenberg
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

Review 10.  Non-steroidal targets in the diagnosis and treatment of endometriosis.

Authors:  C M Kyama; A Mihalyi; P Simsa; J M Mwenda; C Tomassetti; C Meuleman; T M D'Hooghe
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more
  52 in total

Review 1.  Potential scenarios leading to ovarian cancer arising from endometriosis.

Authors:  Hiroshi Kobayashi
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

Review 2.  The endometrial immune environment of women with endometriosis.

Authors:  Júlia Vallvé-Juanico; Sahar Houshdaran; Linda C Giudice
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

Review 3.  Relating Chronic Pelvic Pain and Endometriosis to Signs of Sensitization and Myofascial Pain and Dysfunction.

Authors:  Jacqueline V Aredo; Katrina J Heyrana; Barbara I Karp; Jay P Shah; Pamela Stratton
Journal:  Semin Reprod Med       Date:  2017-01-03       Impact factor: 1.303

Review 4.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

5.  Differential connectivity of gene regulatory networks distinguishes corticosteroid response in asthma.

Authors:  Weiliang Qiu; Feng Guo; Kimberly Glass; Guo Cheng Yuan; John Quackenbush; Xiaobo Zhou; Kelan G Tantisira
Journal:  J Allergy Clin Immunol       Date:  2017-07-20       Impact factor: 10.793

6.  Immune-inflammation gene signatures in endometriosis patients.

Authors:  Soo Hyun Ahn; Kasra Khalaj; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade
Journal:  Fertil Steril       Date:  2016-07-27       Impact factor: 7.329

7.  IL-1β Stimulates Brain-Derived Neurotrophic Factor Production in Eutopic Endometriosis Stromal Cell Cultures: A Model for Cytokine Regulation of Neuroangiogenesis.

Authors:  Jie Yu; Antônio M C Francisco; Bansari G Patel; J Mark Cline; Eric Zou; Sarah L Berga; Robert N Taylor
Journal:  Am J Pathol       Date:  2018-07-20       Impact factor: 4.307

8.  Biomimetic tissue-engineered systems for advancing cancer research: NCI Strategic Workshop report.

Authors:  Teresa K Schuessler; Xin Yi Chan; Huanhuan Joyce Chen; Kyungmin Ji; Kyung Min Park; Alireza Roshan-Ghias; Pallavi Sethi; Archana Thakur; Xi Tian; Aranzazu Villasante; Ioannis K Zervantonakis; Nicole M Moore; Larry A Nagahara; Nastaran Z Kuhn
Journal:  Cancer Res       Date:  2014-08-05       Impact factor: 12.701

9.  Multiple Beneficial Roles of Repressor of Estrogen Receptor Activity (REA) in Suppressing the Progression of Endometriosis.

Authors:  Yuechao Zhao; Yiru Chen; Ye Kuang; Milan K Bagchi; Robert N Taylor; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2015-12-14       Impact factor: 4.736

10.  Research Priorities for Endometriosis.

Authors:  Peter A W Rogers; G David Adamson; Moamar Al-Jefout; Christian M Becker; Thomas M D'Hooghe; Gerard A J Dunselman; Asgerally Fazleabas; Linda C Giudice; Andrew W Horne; M Louise Hull; Lone Hummelshoj; Stacey A Missmer; Grant W Montgomery; Pamela Stratton; Robert N Taylor; Luk Rombauts; Philippa T Saunders; Katy Vincent; Krina T Zondervan
Journal:  Reprod Sci       Date:  2016-09-27       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.